The largest database of trusted experimental protocols

2 protocols using fitc 1 a 1 e

1

Murine Colon Carcinoma Cell Line MC38 for Immunotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine colon carcinoma cell line MC38 was ordered from Suzhou LongMab Biosciences, Suzhou, China. BMDCs were separated from female C57BL/6 mice and sorted using EasySep™ Mouse CD11c Positive Selection Kit II (STEMCELL, Vancouver, Canada) according to the manufacturer's instructions. Anti-mouse CD16/32 antibody and mouse antibodies of FITC-H-2Kb/H-2Db, FITC-I-A/I-E, PE/APC-CD11c, FITC-CD40, FITC-CD80, FITC-CD86 and PE-CCR7 were all purchased from BioLegend, San Diego, CA, USA. All cytokines used in this work were kindly provided by Novoprotein, Shanghai, China. Primary anti-NY-ESO-1 and anti-His rabbit antibodies are CST products (Danvers, MA, USA), and secondary goat anti-rabbit Alexa fluor 488 antibody is a product of Invitrogen, Carlsbad, CA, USA. The proteasome inhibitor lactacystin was bought from APExBIO, Houston, TX, USA. SYBR GREEN qPCR mix was purchased from Vazyme Biotech, Nanjing, China. All ELISA kits and the mouse IFN-γ ELISPOT kit were obtained from DAKEWE Biotech, Beijing, China. Mouse MIP-3β (CCL19) was purchased from Peprotech, Cranbury, NJ, USA.
+ Open protocol
+ Expand
2

Phenotyping Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
DC (2 × 106 cells) and spleen lymphocytes (2 × 106 cells) were incubated with APC-CD11c (BioLegend, cat.117310), PE-CD80 (BioLegend, cat.104707), PE-CD86 (BioLegend, cat.105007), PE-CD40 (BioLegend, cat.124609), FITC-I-A/I-E (BioLegend, cat.), PE-CD3 (BioLegend, cat.100205), PerCP-CD4 (BioLegend, cat.100431), and FITC-CD8 (BioLegend, cat.100705) antibodies and the proportion of positive cells was analyzed by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!